Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil citrate versus nifedipine in women with recurrent miscarriage
PACTR201710002662398Recruiting
- Sponsor
- Menoufia University Hospitals
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sildenafil and nifedipine in recurrent miscarriage (RPL) (3 arms), sponsored by Menoufia University Hospitals. Primary endpoints: Uterine artery blood flow changes and Endometrial thickness. Started Oct 2016; status: recruiting.
02
Drugs
sildenafilnifedipine
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on PACTR201710002662398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201710002662398.